“affymax”

Investigating a new treatment alternative for anemia management. Affymax, Inc

Affymax is a biopharmaceutical company developing drugs to improve the treatment of serious and often life-threatening conditions. The company?s product candidate, Hematide?, is being evaluated to treat anemia associated with chronic renal failure